Cardioprotective profile of MET-88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts

Fundamental and Clinical Pharmacology

Volumn 12, Issue 2, 1998, Pages 158-163

  Asaka, N ^a   Muranaka, Y ^a   Kirimoto, T ^a   Miyake, H ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Carbohydrate and energy metabolism; Hypoxia; Long chain acylcarnitine; MET 88; Rat heart

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARNITINE DERIVATIVE; DIHYDROXYACETONE PHOSPHATE; FRUCTOSE 1,6 BISPHOSPHATE; FRUCTOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE; INSULIN; LACTIC ACID; MILDRONATE; PALMITIC ACID; PHOSPHATE;

ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID OXIDATION; GLUCOSE OXIDATION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HYPOXIA; IN VITRO STUDY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0031978533     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1998.tb00936.x     Document Type: Article

References (25)

1. Baydoun AR, Markham A, Morgan RM, Seetman AJ. Palmitoyl carnitine: an endogenous promoter of calcium efflux from rat heart mitochondria. Biochem Pharmacol 1988 ; 37 : 3103-7
2. Bedford GK, Chiong MA. High-performance liquid Chromatographic method for the simultaneous determination of myocardial creatine phosphate and adenosine nucleotides. J Chromatogr 1984; 305: 183-7
3. Bergmeyer HU. Methods of Enzymatic Analysis, 3rd edition. New York, San Francisco, London: Verlag Chemie Weinheim, Academic Press, Inc; 1988. p 191-8, 342-50
4. Broderick TL, Christos SC, Wolf BA, DiDomenico D, Shug AL, Paulson DJ. Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency. Metabolism 1995 ; 44 : 499-505
5. Busselen P, Sercu D, Verdonck F. Exogenous palmitoyl carnitine and membrane damage in rat hearts. J Mol Cell Cardiol 1988 ; 20 : 905-16
6. Cederblad G, Lindstedt SA. Method for the determination of carnitine in the picomole range. Clin Chim Acta 1972 ; 37 : 235-43
7. Chung CD, Bieber LL. Properties of the medium chain/Long chain carnitine acyltransferase purified from rat liver microsomes. J Biol Chem 1993 ; 268 : 4519-24
8. Clark B, Wyatt KM, May GR, McCormack JG. On the roles of long-chain acyl carnitine accumulation and impaired glucose utilization in ischemic contracture development and tissue damage in the guinea-pig heart. J Mol Cell Cardiol 1996 ; 28 : 171-81
9. Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 1984; 55: 135-54
10. Depre C, Rider MH, Veitch K, Hue L. Role of fructose 2,6-bisphosphate in the control of heart glycolysis. J Biol Chem 1993 ; 268: 13274-9
11. Dhar PK, Grupp IL, Schwartz A, Grupp G, Mohammed A. Reduction of carnitine content by inhibition of its biosynthesis results in protection of isolated guinea pig hearts against hypoxic damage. J Cardiovasc Pharmacol Therapeut 1996 ; 1 : 235-42
12. Horiuchi M, Yoshida H, Kobayashi K, Kuriwaki K, Yoshimine K, Tomomura M et al. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett 1993 ; 326 : 267-71
13. Katz AM, Messineo FC. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 1981 ; 48 : 1-16
14. Kirimoto T, Nobori K, Asaka N, Muranaka Y, Tajima K, Miyake H. Beneficial effect of MET-88, a γ-butyrobetaine hydroxylase inhibitor, on energy metabolism in ischemic dog hearts. Arch Int Pharmacodyn Ther 1996 ; 331 : 163-78
15. Knabb MT, Saffitz JE, Corr PB, Sobel BE. The dependence of electrophysiological derangements on accumulation of endogenous long-chain acyl carnitine in hypoxic neonatal rat myocytes. Circ Res 1986 ; 58 : 230-40
16. Kreher P, Verdetti J. Role of ATP in the maintenance of action potential configuration of the isolated working rat heart. Cardiovasc Res 1986; 20: 89-99
17. Lamers JMJ, Jonge-Stinis JT, Verdouw PD, Hülsmann WC. On the possible role of long chain fatty acylcarnitine accumulation in producing functional and calcium permeability changes in membranes during myocardial ischaemia. Cardiovasc Res 1987; 21 : 313-22
18. Lopaschuk GD, McNeil GF, McVeigh JJ. Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir. Mol Cell Biochem 1989; 88: 175-9
19. Morris GS, Zhou Q, Wolf BA, Christos SC, DiDomenico DF, Shug AL, Paulson DJ. Sodium pivalate reduces cardiac carnitine content and increases glucose oxidation without affecting cardiac functional capacity. Life Sci 1995 ; 57 : 2237-44
20. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972 ; 15 : 289-330
21. Paulson DJ, Shug AL. Tissue specific depletion of L-carnitine in rat heart and skeletal muscle by D-carnitine. Life Sci 1981 ; 28 : 2931-8
22. Paulson DJ, Noonan JJ, Ward KM, Stanley H, Sherratt A, Shug AL. Effects of POCA on metabolism and function in the ischemic rat heart. Basic Res Cardiol 1986 ; 81 : 180-7
23. Pearce FJ, Forster J, De Leeuw G, Williamson JR, Tutwiler GF. Inhibition of fatty acid oxidation in normal and hypoxic perfused rat hearts by 2-Tetradecylglycidic acid. J Mol Cell Cardiol 1979 ; 11 : 895-915
24. Schulz H. Inhibitors of fatty acid oxidation. Life Sci 1987 ; 40 : 1443-9
25. Simkhovich BZ, Shutenko ZHV, Meirena DV, Khagi KHB, Mezapuke RJ, Molodchina TN, Kalvins IJ, Lukevics E. 3-(2,2,2-trimethyl hydrazinium)-propionate (THP): A novel γ-butyrobetaine hydroxylase inhibitor with cardioprotective properties. Biochem Pharmacol 1988 ; 37 : 195-202